A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study

BACKGROUND: The current standard postoperative treatment for stage II-IIIA non-small cell lung cancer (NSCLC) is a regimen of platinum doublet adjuvant chemotherapy. These regimens, which are the same as for solid NSCLC tumors, often cause severe adverse reactions in the treated patients. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Tomoshi, Matsumoto, Keitaro, Miyazaki, Takuro, Doi, Ryoichiro, Tokunaga, Shoji, Yamaguchi, Hiroyuki, Tomoshige, Koichi, Watanabe, Hironosuke, Nagayasu, Takeshi, Sugio, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941711/
https://www.ncbi.nlm.nih.gov/pubmed/33685421
http://dx.doi.org/10.1186/s12885-021-07945-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941711/
https://www.ncbi.nlm.nih.gov/pubmed/33685421
http://dx.doi.org/10.1186/s12885-021-07945-y

Ejemplares similares